Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Content Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Op-Ed
May 10, 2021
On May 5, President Joe Biden announced that the United States would support an international bid to waive intellectual property rights to vaccines for the duration of the coronavirus pandemic, thereby ostensibly allowing other countries to ramp up production even of the sophisticated technology beh...
Op-Ed
May 06, 2021
Big Pharma offers an easy punching bag. To some extent, the hostility is understandable. Pharmaceutical companies make their money by selling lifesaving innovations that they alone control. When prices are too high, people are forced into poverty to pay for medicine, or they get sick and die for lac...
Op-Ed
March 09, 2021
Owing to years of grassroots mobilization and the rise of renewables and low-carbon assets, financial markets are finally shifting gears to account for the inevitable decline of fossil fuels. But to make the most of the current moment, policymakers must heed the financial industry's call for clear s...